These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8410484)

  • 21. [Biological function of AGE].
    Nagai R; Horiuchi S
    Nihon Ronen Igakkai Zasshi; 1998 Apr; 35(4):258-64. PubMed ID: 9643005
    [No Abstract]   [Full Text] [Related]  

  • 22. A potential role for glycated cross-links in abdominal aortic aneurysm disease.
    Koole D; van Herwaarden JA; Schalkwijk CG; Lafeber FPJG; Vink A; Smeets MB; Pasterkamp G; Moll FL
    J Vasc Surg; 2017 May; 65(5):1493-1503.e3. PubMed ID: 27624703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.
    Vasan S; Foiles PG; Founds HW
    Expert Opin Investig Drugs; 2001 Nov; 10(11):1977-87. PubMed ID: 11772301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end products, diabetes and ageing.
    Nass N; Bartling B; Navarrete Santos A; Scheubel RJ; Börgermann J; Silber RE; Simm A
    Z Gerontol Geriatr; 2007 Oct; 40(5):349-56. PubMed ID: 17943238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protein glycation--clinical and chemical aspects].
    Szymańska U; Boratyński J
    Postepy Hig Med Dosw; 1999; 53(5):689-703. PubMed ID: 10645144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging.
    Monnier VM
    Biochem J; 2006 Oct; 399(2):e11-3. PubMed ID: 16987105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation end products of the Maillard reaction and their relation to aging.
    Horiuchi S; Araki N
    Gerontology; 1994; 40 Suppl 2():10-5. PubMed ID: 7926861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):329-36. PubMed ID: 8086514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation in diabetes, aging and age-related diseases: conclusions.
    Monnier VM; Taniguchi N
    Glycoconj J; 2016 Aug; 33(4):691-2. PubMed ID: 27421862
    [No Abstract]   [Full Text] [Related]  

  • 31. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
    Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
    J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum.
    Mitsuhashi T; Vlassara H; Founds HW; Li YM
    J Immunol Methods; 1997 Aug; 207(1):79-88. PubMed ID: 9328589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
    Méndez JD
    Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glycation, glycoxidation and diabetes mellitus].
    Boulanger E; Wautier JL; Dequiedt P; Schmidt AM
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S8-16. PubMed ID: 17378134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylglyoxal - An emerging biomarker for diabetes mellitus diagnosis and its detection methods.
    Ramachandra Bhat L; Vedantham S; Krishnan UM; Rayappan JBB
    Biosens Bioelectron; 2019 May; 133():107-124. PubMed ID: 30921627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced nonenzymatic tissue glycosylation: cell-mediated interactions implicated in the complications associated with diabetes and aging.
    Vlassara H
    Blood Purif; 1990; 8(4):223-32. PubMed ID: 1964791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
    Monnier VM; Genuth S; Sell DR
    Glycoconj J; 2016 Aug; 33(4):569-79. PubMed ID: 27342131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins.
    Poggioli S; Bakala H; Friguet B
    Exp Gerontol; 2002; 37(10-11):1207-15. PubMed ID: 12470833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.